Calidi Biotherapeutics, Inc.

CLDI · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$9,591$2,049$372$2,137
Short-Term Investments$0$0$0$0
Receivables$0$1,360$0$0
Inventory$0$0$0$0
Other Curr. Assets$636$894$414$603
Total Curr. Assets$10,227$4,303$786$2,740
Property Plant & Equip (Net)$2,934$5,343$1,086$585
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$129$230$0$0
Tax Assets$0$0$0$0
Other NC Assets$892$143$725$66
Total NC Assets$3,955$5,716$1,811$651
Other Assets$0$0$0$0
Total Assets$14,182$10,019$2,597$3,391
Liabilities
Payables$2,072$2,877$2,124$624
Short-Term Debt$4,446$1,923$5,541$5,138
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$2,978$5,432$35,324$20,197
Total Curr. Liab.$9,496$10,232$42,989$25,959
LT Debt$2,590$5,313$447$43
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$128$2,709$9,601$0
Total NC Liab.$2,718$8,022$10,048$43
Other Liabilities$0$0$0$0
Cap. Leases$3,260$4,369$563$179
Total Liabilities$12,214$18,254$53,037$26,002
Equity
Pref Stock$0$0$0$9,001
Common Stock$2$4$2$2
Retained Earnings-$121,715-$99,572-$70,356-$44,929
AOCI-$28-$47-$14-$1
Other Equity$123,275$91,380$19,928$13,316
Total Equity$1,534-$8,235-$50,440-$22,611
Supplemental Information
Minority Interest$434$0$0$0
Total Liab. & Tot. Equity$14,182$10,019$2,597$3,391
Net Debt-$2,555$5,187$5,616$3,044